On August 18, 2010
What Does Watson CEO Paul Bisaro Know and Why Won’t He Tell the FTC?
A federal judge has ruled that Watson Pharmaceuticals (WPI) CEO Paul Bisaro must sit for an FTC deposition about his pay-for-delay dealings with Cephalon (CEPH), ending his long, conspicuous…
No tags for this post.
0 Comments